Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CNTA | US
0.49
4.76%
Healthcare
Biotechnology
31/03/2024
26/07/2024
10.78
10.29
10.82
10.18
Centessa Pharmaceuticals plc a clinical-stage pharmaceutical company discovers develops and delivers medicines to patients. Its pipeline products include SerpinPC an activated protein C inhibitor which is in Phase IIa clinical development for the treatment of hemophilia A and B; and ORX750 an orally administered OX2R agonist for the treatment of NT1 with potential expansion into other sleep disorders. The company also develops LB101 a PD-L1xCD47 LockBody which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; ZF874 in alpha-1 antitrypsin deficiency a dual-STAT3/5 degrader program in acute myeloid leukemia (AML); MGX292 a protein-engineered variant of human bone morphogenetic protein 9 (BMP9) for the treatment of pulmonary arterial hypertension (PAH); and OX2R Agonists compounds are currently in development for the treatment of narcolepsy including TAK-861. In addition its products pipeline comprises CBS001 a neutralizing therapeutic mAb to the inflammatory membrane form of LIGHT for inflammatory / fibrotic diseases; and CBS004 a therapeutic mAb targeting BDCA-2 for the potential treatment of autoimmune diseases as well as earlier-stage preclinical assets including ORX750 an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and discovery-stage programs in certain other disease areas. Centessa Pharmaceuticals plc was incorporated in 2020 and is based in Altrincham the United Kingdom.
View LessPositive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
50.8%1 month
50.2%3 months
52.1%6 months
71.5%-
-
4.95
0.40
0.26
1.12
134.53
-
-158.14M
1.22B
1.22B
-
-2.31K
-
-
-54.45
4.82
1.29
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.82
Range1M
2.36
Range3M
3.07
Rel. volume
2.88
Price X volume
8.86M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Xencor Inc | XNCR | Biotechnology | 21.65 | 1.33B | 1.79% | n/a | 14.58% |
ANI Pharmaceuticals Inc | ANIP | Biotechnology | 63.25 | 1.33B | 1.97% | 38.63 | 68.66% |
Ardelyx Inc | ARDX | Biotechnology | 5.62 | 1.31B | 2.37% | n/a | 69.54% |
Prothena Corporation plc | PRTA | Biotechnology | 24.43 | 1.31B | -1.45% | n/a | 2.49% |
Ocular Therapeutix Inc | OCUL | Biotechnology | 8.43 | 1.31B | 1.81% | n/a | 18.24% |
immatics biotechnologies GmbH | IMTX | Biotechnology | 12.3 | 1.27B | -0.73% | n/a | 8.13% |
Autolus Therapeutics Plc | AUTL | Biotechnology | 4.67 | 1.24B | 1.52% | n/a | 48.08% |
ELVN | ELVN | Biotechnology | 27.31 | 1.24B | 9.15% | n/a | 0.08% |
Relay Therapeutics Inc. | RLAY | Biotechnology | 8.94 | 1.19B | -1.32% | n/a | 7.01% |
ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 10.07 | 1.17B | -0.30% | n/a | 91.91% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.74 | 1.21B | 1.20% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 22.48 | 1.01B | 4.66% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.16 | 800.41M | 5.13% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 23.82 | 618.94M | 0.76% | 14.34 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.11 | 488.72M | 1.19% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 30.4 | 487.11M | 1.33% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 14.3 | 449.64M | 2.36% | 15.90 | 86.68% |
Latham Group Inc. | SWIM | Building Products & Equipment | 3.52 | 406.82M | 7.65% | 77.50 | 80.81% |
Marine Products Corporation | MPX | Recreational Vehicles | 10.66 | 369.72M | 2.01% | 10.15 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 21.09 | 358.13M | 1.93% | 8.78 | 25.57% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.12 | -2.85 | Expensive |
Ent. to Revenue | 134.53 | 4,050.30 | Cheaper |
PE Ratio | - | 39.84 | - |
Price to Book | 4.95 | 22.96 | Cheaper |
Dividend Yield | - | 1.79 | - |
Std. Deviation (3M) | 52.13 | 75.85 | Lower Risk |
Debt to Equity | 0.40 | 0.55 | Cheaper |
Debt to Assets | 0.26 | 0.24 | Par |
Market Cap | 1.22B | 3.61B | Emerging |